Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.
about
Met receptors induce Sam68-dependent cell migration by activation of alternate extracellular signal-regulated kinase family membersMet receptor acts uniquely for survival and morphogenesis of EGFR-dependent normal mammary epithelial and cancer cellsProtein-tyrosine kinase 6 promotes peripheral adhesion complex formation and cell migration by phosphorylating p130 CRK-associated substrateThe oleocanthal-based homovanillyl sinapate as a novel c-Met inhibitorCancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition.Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer modelsKinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancerHIF-1α-independent hypoxia-induced rapid PTK6 stabilization is associated with increased motility and invasion.Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.Expression of the phosphorylated MEK5 protein is associated with TNM staging of colorectal cancer.Cytoplasmic retention of protein tyrosine kinase 6 promotes growth of prostate tumor cells.Pathways driving the endocytosis of mutant and wild-type EGFR in cancer.Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression.PTK6 promotes cancer migration and invasion in pancreatic cancer cells dependent on ERK signaling.MAPK7 Regulates EMT Features and Modulates the Generation of CTCs.Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis.A comparison of epithelial-to-mesenchymal transition and re-epithelializationBreast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast CancerProtein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis.ERK5 and its role in tumour development.Context-specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer.PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer.Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.Microenvironment induced spheroid to sheeting transition of immortalized human keratinocytes (HaCaT) cultured in microbubbles formed in polydimethylsiloxane.Targeting the BMK1 MAP kinase pathway in cancer therapy.Targeting protein tyrosine kinase 6 enhances apoptosis of colon cancer cells following DNA damage.ERBB2 Activates PTK6 SignalingSignaling by PTK6PD2/PAF1 at the Crossroads of the Cancer Network.miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5.
P2860
Q24606871-31267A42-DB62-4779-85AF-D89144B7185BQ27318931-6B66FD6F-8C14-49D5-A84F-B77987E3FBB2Q28115210-80032025-6148-44F7-A90E-D0F3C8E6B9D7Q28821187-53A83F56-06E6-42B4-BC07-B18E6EAE3B52Q30009178-55C7F24F-4FCD-448A-95F1-5A7881285962Q33645135-EBA16A12-9708-4E0B-A856-0C2BBF6F4E8AQ33917578-9D244918-5E05-4987-9425-BD63DC618F4CQ34036107-B8ACC8A0-B671-4443-B006-B5C2A1189673Q34085432-CB3CBE6A-7DC9-430F-86D9-1A45E6D9B671Q34212935-E3F2F6B4-6889-457E-8EA6-4F20C0601849Q34659926-D6AF532D-D3F7-49B4-94FC-7A9B92E9F0E0Q34781357-C751BD6E-8BDE-4C6A-A245-9AD21B6D089CQ34912116-9C748820-0194-4B24-A0A0-DE5AC013AFBCQ35161670-47707B77-2B4F-41A2-A22F-434F001D36B1Q35560430-B1B97461-3787-42E8-8239-E7E22AE69084Q35683544-28389D35-FECB-4D39-A6F1-A734C405425DQ35834635-FBB95422-6593-429B-B3F4-FF2ECEEC3FBCQ36080701-70EBF430-B7C6-4726-9856-C0575487E5A2Q36678367-FF1A7518-4AF7-4DFB-A6D4-D15454B364EEQ36693131-41EF990A-A115-431E-8637-29AFD6DCE019Q36940726-E2ACD242-6BAE-4404-B05C-514742BF3428Q37977186-BF036A36-0213-44B2-A883-192518BA0D31Q38080556-348AABD5-6871-4C7C-817E-B68B29F30CAAQ39125642-25A74034-07B1-4512-9AEA-E36DC4124FE1Q39268132-4D1A8359-34F1-4AED-8EBD-CD0FF128B872Q39514016-72BF6108-DDCF-4C08-AB85-AEBCED460174Q41905885-AFE5AF4A-56B1-4374-B49C-8637863C6028Q42357549-C01BD600-2CCC-47B0-B794-47F5C88836C4Q45318098-5882D1F6-E011-49B3-B737-A7956DC6FE86Q45318326-E54E6D62-FED1-4EC7-A41F-F8ED8812148BQ50133871-C74776B0-AFC6-40E1-8AA1-EF078B0FDCD4Q54231260-50CE5D3E-3F58-4D61-802D-6E514F2CAE7A
P2860
Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Breast tumor kinase and extrac ...... ration in breast cancer cells.
@ast
Breast tumor kinase and extrac ...... ration in breast cancer cells.
@en
Breast tumor kinase and extrac ...... ration in breast cancer cells.
@nl
type
label
Breast tumor kinase and extrac ...... ration in breast cancer cells.
@ast
Breast tumor kinase and extrac ...... ration in breast cancer cells.
@en
Breast tumor kinase and extrac ...... ration in breast cancer cells.
@nl
prefLabel
Breast tumor kinase and extrac ...... ration in breast cancer cells.
@ast
Breast tumor kinase and extrac ...... ration in breast cancer cells.
@en
Breast tumor kinase and extrac ...... ration in breast cancer cells.
@nl
P2860
P356
P1476
Breast tumor kinase and extrac ...... ration in breast cancer cells.
@en
P2093
Carol A Lange
Nancy E Castro
P2860
P2888
P356
10.1186/BCR2622
P577
2010-08-05T00:00:00Z
P5875
P6179
1045029496